Home/Filings/4/0001213900-21-021025
4//SEC Filing

Rothbard Jonathan B. 4

Accession 0001213900-21-021025

CIK 0001690080other

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 4:15 PM ET

Size

4.9 KB

Accession

0001213900-21-021025

Insider Transaction Report

Form 4
Period: 2021-04-07
Rothbard Jonathan B.
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2021-04-07$6.14/sh+24,307$149,245560,449 total
Footnotes (1)
  • [F1]Issued in consideration for accrued compensation due for services rendered as Chief Scientific Officer of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1
  • filerCIK 0001833968

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:15 PM ET
Size
4.9 KB